about
Current status of erythrocyte substitutesSite-selective glycosylation of hemoglobin on Cys beta93.Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications.Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma.Blood substitutes.
P2860
description
1970 nî lūn-bûn
@nan
1970 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1970 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1970年の論文
@ja
1970年論文
@yue
1970年論文
@zh-hant
1970年論文
@zh-hk
1970年論文
@zh-mo
1970年論文
@zh-tw
1970年论文
@wuu
name
Further studies with stroma-free hemoglobin solution
@ast
Further studies with stroma-free hemoglobin solution
@en
Further studies with stroma-free hemoglobin solution
@nl
type
label
Further studies with stroma-free hemoglobin solution
@ast
Further studies with stroma-free hemoglobin solution
@en
Further studies with stroma-free hemoglobin solution
@nl
prefLabel
Further studies with stroma-free hemoglobin solution
@ast
Further studies with stroma-free hemoglobin solution
@en
Further studies with stroma-free hemoglobin solution
@nl
P2093
P2860
P1433
P1476
Further studies with stroma-free hemoglobin solution
@en
P2093
G W Peskin
L H Friedman
S F Rabiner
P2860
P304
P356
10.1097/00000658-197004000-00020
P407
P577
1970-04-01T00:00:00Z